Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)-Reference-Cited by-同舟云学术

Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)

Published:2017-02 Issue:10068 Volume:389 Page:505-518
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Henao-Restrepo Ana Maria,Camacho Anton,Longini Ira M,Watson Conall H,Edmunds W John,Egger Matthias,Carroll Miles W,Dean Natalie E,Diatta Ibrahima,Doumbia Moussa,Draguez Bertrand,Duraffour Sophie,Enwere Godwin,Grais Rebecca,Gunther Stephan,Gsell Pierre-Stéphane,Hossmann Stefanie,Watle Sara Viksmoen,Kondé Mandy Kader,Kéïta Sakoba,Kone Souleymane,Kuisma Eewa,Levine Myron M,Mandal Sema,Mauget Thomas,Norheim Gunnstein,Riveros Ximena,Soumah Aboubacar,Trelle Sven,Vicari Andrea S,Røttingen John-Arne,Kieny Marie-Paule

Publisher

Elsevier BV

Subject

General Medicine

Reference27 articles.

1. Ebola vaccine—an urgent international priority;Kanapathipillai;N Engl J Med,2014

2. Ebola virus vaccines: an overview of current approaches;Marzi;Expert Rev Vaccines,2014

3. Assessment of a vesicular stomatitis virus-based vaccine by use of the mouse model of Ebola virus hemorrhagic fever;Jones;J Infect Dis,2007

4. Immunization with vesicular stomatitis virus vaccine expressing the Ebola glycoprotein provides sustained long-term protection in rodents;Wong;Vaccine,2014

5. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses;Jones;Nat Med,2005

Cited by 825 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Viral Diseases;Pulmonary Pathology;2025

2. Current status and research progress of oncolytic virus;Pharmaceutical Science Advances;2024-12

3. Recent Advances in Therapeutic Approaches Against Ebola Virus Infection;Recent Advances in Anti-Infective Drug Discovery;2024-11

4. Replication, safety and immunogenicity of the vectored Ebola vaccine rVSV-ΔG-ZEBOV-GP in a sub-Saharan African paediatric population: A randomised controlled, open-label trial in children aged 1-12 years living in Lambaréné, Gabon;Journal of Infection;2024-10

5. Mosaic neuraminidase-based vaccine induces antigen-specific T cell responses against homologous and heterologous influenza viruses;Antiviral Research;2024-10